Page last updated: 2024-09-03

sch 39370 and n-(1-carboxy-3-phenylpropyl)-alanyl-alanyl-phenylalanine-4-aminobenzoate

sch 39370 has been researched along with n-(1-carboxy-3-phenylpropyl)-alanyl-alanyl-phenylalanine-4-aminobenzoate in 1 studies

Compound Research Comparison

Studies
(sch 39370)
Trials
(sch 39370)
Recent Studies (post-2010)
(sch 39370)
Studies
(n-(1-carboxy-3-phenylpropyl)-alanyl-alanyl-phenylalanine-4-aminobenzoate)
Trials
(n-(1-carboxy-3-phenylpropyl)-alanyl-alanyl-phenylalanine-4-aminobenzoate)
Recent Studies (post-2010) (n-(1-carboxy-3-phenylpropyl)-alanyl-alanyl-phenylalanine-4-aminobenzoate)
25101600

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Evans, RG; Lew, RA; Madden, AC; Smith, AI; Tomoda, F1

Other Studies

1 other study(ies) available for sch 39370 and n-(1-carboxy-3-phenylpropyl)-alanyl-alanyl-phenylalanine-4-aminobenzoate

ArticleYear
Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
    British journal of pharmacology, 1996, Volume: 119, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Consciousness; Dipeptides; Enzyme Inhibitors; Heart Rate; Kidney; Metalloendopeptidases; Neprilysin; Oligopeptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Rabbits; Receptors, Bradykinin

1996